CA Stock MarketDetailed Quotes

CVM.H CVR Medical Corp

Watchlist
  • 0.015
  • 0.0000.00%
15min DelayMarket Closed Apr 11 09:30 ET
1.61MMarket Cap-416P/E (TTM)

CVR Medical Corp Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-38.75%109.76K
192.92%108.69K
-55.19%143.43K
598.21%593.25K
146.07%210.93K
2.30%179.2K
-208.85%-116.97K
23.03%320.09K
-98.29%84.97K
-143.06%-457.85K
Selling and administrative expenses
-38.30%109.76K
192.80%108.69K
-51.09%143.4K
2,227.00%564.83K
146.05%210.87K
6.21%177.89K
-208.03%-117.12K
42.12%293.19K
-99.16%24.27K
-191.75%-457.93K
-General and administrative expense
-38.30%109.76K
192.80%108.69K
-51.09%143.4K
2,227.00%564.83K
146.05%210.87K
6.21%177.89K
-208.03%-117.12K
42.12%293.19K
-99.16%24.27K
-191.75%-457.93K
Research and development costs
--0
--0
--0
-53.41%28.17K
-126.92%-7
-83.53%1.26K
108.59%86
-50.14%26.83K
-97.10%60.46K
-100.00%26
Depreciation amortization depletion
--0
--0
-49.18%31
6.90%248
3.33%62
6.90%62
12.50%63
5.17%61
-0.85%232
1.69%60
-Depreciation and amortization
--0
--0
-49.18%31
6.90%248
3.33%62
6.90%62
12.50%63
5.17%61
-0.85%232
1.69%60
Operating profit
38.75%-109.76K
-192.92%-108.69K
55.19%-143.43K
-598.21%-593.25K
-146.07%-210.93K
-2.30%-179.2K
208.85%116.97K
-23.03%-320.09K
98.29%-84.97K
143.06%457.85K
Net non-operating interest income (expenses)
-13.82%-21.47K
-11.20%-20.14K
-6.84%-19.55K
2.58%-74.4K
12.52%-19.12K
14.65%-18.87K
-94.52%-18.11K
20.77%-18.3K
17.21%-76.37K
2.14%-21.86K
Non-operating interest expense
15.92%21.25K
10.30%19.57K
6.89%19.2K
-1.49%72.86K
-12.25%18.83K
-13.29%18.33K
98.01%17.74K
-19.84%17.96K
-22.13%73.97K
-7.61%21.46K
Total other finance cost
-57.54%228
54.62%569
4.12%354
-36.19%1.53K
-26.97%287
-44.41%537
5.14%368
-50.87%340
-51.48%2.4K
-56.57%393
Other net income (expenses)
-180.22%-127.36K
-226.47%-61.76K
1,074.43%28.1K
-9,429.93%-1.15M
-400.49%-1.16M
60.29%-45.45K
123.15%48.84K
103.36%2.39K
80.63%-12.07K
398.40%384.63K
Gain on sale of security
-235.50%-117.24K
-188.56%-52.12K
212.47%37.3K
-60.65%13.43K
-105.20%-22.41K
69.47%-34.95K
127.90%58.85K
116.75%11.94K
-55.20%34.14K
4,385.49%430.83K
Special income (charges)
3.66%-10.12K
3.68%-9.65K
3.67%-9.19K
-2,417.93%-1.16M
-2,352.87%-1.13M
---10.51K
---10.01K
---9.54K
66.64%-46.21K
---46.21K
-Less:Restructuring and mergern&acquisition
-3.66%10.12K
-3.68%9.65K
-3.67%9.19K
-120.24%-9.35K
-185.30%-39.42K
--10.51K
--10.01K
--9.54K
--46.21K
--46.21K
-Less:Impairment of capital assets
----
----
----
--1.17M
----
----
----
----
--0
----
Income before tax
-6.19%-258.6K
-229.04%-190.59K
59.86%-134.88K
-948.22%-1.82M
-268.87%-1.39M
21.88%-243.52K
145.07%147.7K
5.23%-335.99K
96.62%-173.4K
167.57%820.62K
Income tax
Earnings from equity interest net of tax
Net income
-6.19%-258.6K
-229.04%-190.59K
59.86%-134.88K
-948.22%-1.82M
-268.87%-1.39M
21.88%-243.52K
145.07%147.7K
5.23%-335.99K
96.62%-173.4K
167.57%820.62K
Net income continuous operations
-6.19%-258.6K
-229.04%-190.59K
59.86%-134.88K
-948.22%-1.82M
-268.87%-1.39M
21.88%-243.52K
145.07%147.7K
5.23%-335.99K
96.62%-173.4K
167.57%820.62K
Noncontrolling interests
Net income attributable to the company
-6.19%-258.6K
-229.04%-190.59K
59.86%-134.88K
-948.22%-1.82M
-268.87%-1.39M
21.88%-243.52K
145.07%147.7K
5.23%-335.99K
96.62%-173.4K
167.57%820.62K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-6.19%-258.6K
-229.04%-190.59K
59.86%-134.88K
-948.22%-1.82M
-268.87%-1.39M
21.88%-243.52K
145.07%147.7K
5.23%-335.99K
96.62%-173.4K
167.57%820.62K
Diluted earnings per share
-0.42%-0.0024
-222.92%-0.0018
61.32%-0.0013
-1,069.59%-0.02
-289.88%-0.0157
21.89%-0.0024
145.07%0.0015
5.23%-0.0033
96.58%-0.0017
182.90%0.0083
Basic earnings per share
-0.42%-0.0024
-222.92%-0.0018
61.32%-0.0013
-1,069.59%-0.02
-294.45%-0.0157
21.89%-0.0024
145.07%0.0015
5.23%-0.0033
96.58%-0.0017
180.95%0.0081
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -38.75%109.76K192.92%108.69K-55.19%143.43K598.21%593.25K146.07%210.93K2.30%179.2K-208.85%-116.97K23.03%320.09K-98.29%84.97K-143.06%-457.85K
Selling and administrative expenses -38.30%109.76K192.80%108.69K-51.09%143.4K2,227.00%564.83K146.05%210.87K6.21%177.89K-208.03%-117.12K42.12%293.19K-99.16%24.27K-191.75%-457.93K
-General and administrative expense -38.30%109.76K192.80%108.69K-51.09%143.4K2,227.00%564.83K146.05%210.87K6.21%177.89K-208.03%-117.12K42.12%293.19K-99.16%24.27K-191.75%-457.93K
Research and development costs --0--0--0-53.41%28.17K-126.92%-7-83.53%1.26K108.59%86-50.14%26.83K-97.10%60.46K-100.00%26
Depreciation amortization depletion --0--0-49.18%316.90%2483.33%626.90%6212.50%635.17%61-0.85%2321.69%60
-Depreciation and amortization --0--0-49.18%316.90%2483.33%626.90%6212.50%635.17%61-0.85%2321.69%60
Operating profit 38.75%-109.76K-192.92%-108.69K55.19%-143.43K-598.21%-593.25K-146.07%-210.93K-2.30%-179.2K208.85%116.97K-23.03%-320.09K98.29%-84.97K143.06%457.85K
Net non-operating interest income (expenses) -13.82%-21.47K-11.20%-20.14K-6.84%-19.55K2.58%-74.4K12.52%-19.12K14.65%-18.87K-94.52%-18.11K20.77%-18.3K17.21%-76.37K2.14%-21.86K
Non-operating interest expense 15.92%21.25K10.30%19.57K6.89%19.2K-1.49%72.86K-12.25%18.83K-13.29%18.33K98.01%17.74K-19.84%17.96K-22.13%73.97K-7.61%21.46K
Total other finance cost -57.54%22854.62%5694.12%354-36.19%1.53K-26.97%287-44.41%5375.14%368-50.87%340-51.48%2.4K-56.57%393
Other net income (expenses) -180.22%-127.36K-226.47%-61.76K1,074.43%28.1K-9,429.93%-1.15M-400.49%-1.16M60.29%-45.45K123.15%48.84K103.36%2.39K80.63%-12.07K398.40%384.63K
Gain on sale of security -235.50%-117.24K-188.56%-52.12K212.47%37.3K-60.65%13.43K-105.20%-22.41K69.47%-34.95K127.90%58.85K116.75%11.94K-55.20%34.14K4,385.49%430.83K
Special income (charges) 3.66%-10.12K3.68%-9.65K3.67%-9.19K-2,417.93%-1.16M-2,352.87%-1.13M---10.51K---10.01K---9.54K66.64%-46.21K---46.21K
-Less:Restructuring and mergern&acquisition -3.66%10.12K-3.68%9.65K-3.67%9.19K-120.24%-9.35K-185.30%-39.42K--10.51K--10.01K--9.54K--46.21K--46.21K
-Less:Impairment of capital assets --------------1.17M------------------0----
Income before tax -6.19%-258.6K-229.04%-190.59K59.86%-134.88K-948.22%-1.82M-268.87%-1.39M21.88%-243.52K145.07%147.7K5.23%-335.99K96.62%-173.4K167.57%820.62K
Income tax
Earnings from equity interest net of tax
Net income -6.19%-258.6K-229.04%-190.59K59.86%-134.88K-948.22%-1.82M-268.87%-1.39M21.88%-243.52K145.07%147.7K5.23%-335.99K96.62%-173.4K167.57%820.62K
Net income continuous operations -6.19%-258.6K-229.04%-190.59K59.86%-134.88K-948.22%-1.82M-268.87%-1.39M21.88%-243.52K145.07%147.7K5.23%-335.99K96.62%-173.4K167.57%820.62K
Noncontrolling interests
Net income attributable to the company -6.19%-258.6K-229.04%-190.59K59.86%-134.88K-948.22%-1.82M-268.87%-1.39M21.88%-243.52K145.07%147.7K5.23%-335.99K96.62%-173.4K167.57%820.62K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -6.19%-258.6K-229.04%-190.59K59.86%-134.88K-948.22%-1.82M-268.87%-1.39M21.88%-243.52K145.07%147.7K5.23%-335.99K96.62%-173.4K167.57%820.62K
Diluted earnings per share -0.42%-0.0024-222.92%-0.001861.32%-0.0013-1,069.59%-0.02-289.88%-0.015721.89%-0.0024145.07%0.00155.23%-0.003396.58%-0.0017182.90%0.0083
Basic earnings per share -0.42%-0.0024-222.92%-0.001861.32%-0.0013-1,069.59%-0.02-294.45%-0.015721.89%-0.0024145.07%0.00155.23%-0.003396.58%-0.0017180.95%0.0081
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data